ralphey, I agree that Vascepa should be promoted as "THE STATIN ENHANCER.", not as lowering triglyceride. At least for short term (for the next 5 years), that would be the best way to change community perception. IMO
Nicely done. If Amarin could put your explanation into a slick marketing package and distribute it to every doctor and pharmacy outlet, it would be worth far more than 1,000 sales reps.